nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ALB—stomach cancer	0.264	1	CbGaD
Cefazolin—ABCC4—Fluorouracil—stomach cancer	0.129	0.271	CbGbCtD
Cefazolin—SLC22A11—Methotrexate—stomach cancer	0.0762	0.161	CbGbCtD
Cefazolin—ABCC4—Methotrexate—stomach cancer	0.0709	0.149	CbGbCtD
Cefazolin—ALB—Irinotecan—stomach cancer	0.0497	0.105	CbGbCtD
Cefazolin—ALB—Fluorouracil—stomach cancer	0.0477	0.1	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—stomach cancer	0.0443	0.0934	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—stomach cancer	0.0309	0.0651	CbGbCtD
Cefazolin—ALB—Methotrexate—stomach cancer	0.0263	0.0554	CbGbCtD
Cefazolin—PON1—blood vessel—stomach cancer	0.0176	0.218	CbGeAlD
Cefazolin—PON1—hematopoietic system—stomach cancer	0.00936	0.116	CbGeAlD
Cefazolin—PON1—lymphoid tissue—stomach cancer	0.00659	0.0816	CbGeAlD
Cefazolin—PON1—bone marrow—stomach cancer	0.006	0.0743	CbGeAlD
Cefazolin—PON1—endocrine gland—stomach cancer	0.00538	0.0666	CbGeAlD
Cefazolin—PON1—liver—stomach cancer	0.00485	0.0601	CbGeAlD
Cefazolin—ALB—gall bladder—stomach cancer	0.00312	0.0387	CbGeAlD
Cefazolin—TPMT—hematopoietic system—stomach cancer	0.00285	0.0353	CbGeAlD
Cefazolin—TPMT—pancreas—stomach cancer	0.00232	0.0287	CbGeAlD
Cefazolin—SLC22A11—digestive system—stomach cancer	0.00209	0.0259	CbGeAlD
Cefazolin—TPMT—bone marrow—stomach cancer	0.00183	0.0226	CbGeAlD
Cefazolin—SLC22A11—endocrine gland—stomach cancer	0.00173	0.0214	CbGeAlD
Cefazolin—ABCC4—hematopoietic system—stomach cancer	0.00171	0.0212	CbGeAlD
Cefazolin—SLC22A8—hematopoietic system—stomach cancer	0.0017	0.021	CbGeAlD
Cefazolin—TPMT—endocrine gland—stomach cancer	0.00164	0.0203	CbGeAlD
Cefazolin—SLC22A11—liver—stomach cancer	0.00156	0.0193	CbGeAlD
Cefazolin—TPMT—liver—stomach cancer	0.00148	0.0183	CbGeAlD
Cefazolin—ABCC4—pancreas—stomach cancer	0.00139	0.0173	CbGeAlD
Cefazolin—ABCC4—digestive system—stomach cancer	0.00119	0.0147	CbGeAlD
Cefazolin—TPMT—lymph node—stomach cancer	0.00113	0.014	CbGeAlD
Cefazolin—ABCC4—bone marrow—stomach cancer	0.0011	0.0136	CbGeAlD
Cefazolin—ABCC4—endocrine gland—stomach cancer	0.000983	0.0122	CbGeAlD
Cefazolin—ALB—liver—stomach cancer	0.000916	0.0113	CbGeAlD
Cefazolin—ABCC4—liver—stomach cancer	0.000886	0.011	CbGeAlD
Cefazolin—ALB—lymph node—stomach cancer	0.000702	0.0087	CbGeAlD
Cefazolin—ABCC4—lymph node—stomach cancer	0.00068	0.00842	CbGeAlD
Cefazolin—Cefotetan—ALB—stomach cancer	0.000437	0.214	CrCbGaD
Cefazolin—Cefpiramide—ALB—stomach cancer	0.00038	0.186	CrCbGaD
Cefazolin—Confusional state—Irinotecan—stomach cancer	0.000334	0.00207	CcSEcCtD
Cefazolin—Hepatic function abnormal—Doxorubicin—stomach cancer	0.000333	0.00206	CcSEcCtD
Cefazolin—Anaphylactic shock—Irinotecan—stomach cancer	0.000331	0.00205	CcSEcCtD
Cefazolin—Cefonicid—ALB—stomach cancer	0.000331	0.162	CrCbGaD
Cefazolin—Shock—Irinotecan—stomach cancer	0.000326	0.00202	CcSEcCtD
Cefazolin—Agranulocytosis—Capecitabine—stomach cancer	0.000324	0.00201	CcSEcCtD
Cefazolin—Thrombocytopenia—Irinotecan—stomach cancer	0.000324	0.00201	CcSEcCtD
Cefazolin—Haemoglobin—Docetaxel—stomach cancer	0.000324	0.00201	CcSEcCtD
Cefazolin—Haemorrhage—Docetaxel—stomach cancer	0.000322	0.002	CcSEcCtD
Cefazolin—Hepatitis—Docetaxel—stomach cancer	0.000322	0.002	CcSEcCtD
Cefazolin—Confusional state—Fluorouracil—stomach cancer	0.00032	0.00198	CcSEcCtD
Cefazolin—Anaphylactic shock—Fluorouracil—stomach cancer	0.000317	0.00197	CcSEcCtD
Cefazolin—Anorexia—Irinotecan—stomach cancer	0.000316	0.00196	CcSEcCtD
Cefazolin—Haemoglobin—Capecitabine—stomach cancer	0.000314	0.00194	CcSEcCtD
Cefazolin—Haemorrhage—Capecitabine—stomach cancer	0.000312	0.00193	CcSEcCtD
Cefazolin—Hepatitis—Capecitabine—stomach cancer	0.000312	0.00193	CcSEcCtD
Cefazolin—Thrombocytopenia—Fluorouracil—stomach cancer	0.000311	0.00192	CcSEcCtD
Cefazolin—Hypotension—Irinotecan—stomach cancer	0.000309	0.00192	CcSEcCtD
Cefazolin—Erythema multiforme—Docetaxel—stomach cancer	0.000305	0.00189	CcSEcCtD
Cefazolin—Anorexia—Fluorouracil—stomach cancer	0.000302	0.00187	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000302	0.00187	CcSEcCtD
Cefazolin—Hypotension—Fluorouracil—stomach cancer	0.000296	0.00184	CcSEcCtD
Cefazolin—Erythema multiforme—Capecitabine—stomach cancer	0.000295	0.00183	CcSEcCtD
Cefazolin—Somnolence—Irinotecan—stomach cancer	0.000294	0.00182	CcSEcCtD
Cefazolin—Blood creatinine increased—Epirubicin—stomach cancer	0.000294	0.00182	CcSEcCtD
Cefazolin—Dyspepsia—Irinotecan—stomach cancer	0.000292	0.00181	CcSEcCtD
Cefazolin—Cefmetazole—ALB—stomach cancer	0.000291	0.143	CrCbGaD
Cefazolin—Decreased appetite—Irinotecan—stomach cancer	0.000288	0.00178	CcSEcCtD
Cefazolin—Eosinophilia—Methotrexate—stomach cancer	0.000287	0.00178	CcSEcCtD
Cefazolin—Abdominal pain upper—Epirubicin—stomach cancer	0.000287	0.00178	CcSEcCtD
Cefazolin—Fatigue—Irinotecan—stomach cancer	0.000286	0.00177	CcSEcCtD
Cefazolin—Pain—Irinotecan—stomach cancer	0.000283	0.00175	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000283	0.00175	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000283	0.00175	CcSEcCtD
Cefazolin—Somnolence—Fluorouracil—stomach cancer	0.000282	0.00175	CcSEcCtD
Cefazolin—Dyspepsia—Fluorouracil—stomach cancer	0.000279	0.00173	CcSEcCtD
Cefazolin—Decreased appetite—Fluorouracil—stomach cancer	0.000276	0.00171	CcSEcCtD
Cefazolin—Pancytopenia—Methotrexate—stomach cancer	0.000276	0.00171	CcSEcCtD
Cefazolin—Feeling abnormal—Irinotecan—stomach cancer	0.000273	0.00169	CcSEcCtD
Cefazolin—Blood creatinine increased—Doxorubicin—stomach cancer	0.000272	0.00169	CcSEcCtD
Cefazolin—Neutropenia—Methotrexate—stomach cancer	0.000271	0.00168	CcSEcCtD
Cefazolin—Pain—Fluorouracil—stomach cancer	0.000271	0.00168	CcSEcCtD
Cefazolin—Gastrointestinal pain—Irinotecan—stomach cancer	0.000271	0.00168	CcSEcCtD
Cefazolin—Eosinophilia—Epirubicin—stomach cancer	0.000269	0.00167	CcSEcCtD
Cefazolin—Flatulence—Capecitabine—stomach cancer	0.000268	0.00166	CcSEcCtD
Cefazolin—Abdominal pain upper—Doxorubicin—stomach cancer	0.000266	0.00164	CcSEcCtD
Cefazolin—Abdominal pain—Irinotecan—stomach cancer	0.000262	0.00162	CcSEcCtD
Cefazolin—Body temperature increased—Irinotecan—stomach cancer	0.000262	0.00162	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000262	0.00162	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000262	0.00162	CcSEcCtD
Cefazolin—Feeling abnormal—Fluorouracil—stomach cancer	0.000261	0.00162	CcSEcCtD
Cefazolin—Anaemia—Docetaxel—stomach cancer	0.000259	0.00161	CcSEcCtD
Cefazolin—Pancytopenia—Epirubicin—stomach cancer	0.000258	0.0016	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000256	0.00159	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—stomach cancer	0.000254	0.00158	CcSEcCtD
Cefazolin—Neutropenia—Epirubicin—stomach cancer	0.000254	0.00157	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—stomach cancer	0.000252	0.00156	CcSEcCtD
Cefazolin—Urticaria—Fluorouracil—stomach cancer	0.000252	0.00156	CcSEcCtD
Cefazolin—Syncope—Docetaxel—stomach cancer	0.000252	0.00156	CcSEcCtD
Cefazolin—Leukopenia—Docetaxel—stomach cancer	0.000251	0.00156	CcSEcCtD
Cefazolin—Anaemia—Capecitabine—stomach cancer	0.000251	0.00156	CcSEcCtD
Cefazolin—Body temperature increased—Fluorouracil—stomach cancer	0.000251	0.00155	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—stomach cancer	0.000249	0.00154	CcSEcCtD
Cefazolin—Loss of consciousness—Docetaxel—stomach cancer	0.000247	0.00153	CcSEcCtD
Cefazolin—Hypersensitivity—Irinotecan—stomach cancer	0.000244	0.00151	CcSEcCtD
Cefazolin—Syncope—Capecitabine—stomach cancer	0.000244	0.00151	CcSEcCtD
Cefazolin—Leukopenia—Capecitabine—stomach cancer	0.000243	0.00151	CcSEcCtD
Cefazolin—Convulsion—Docetaxel—stomach cancer	0.000243	0.00151	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—stomach cancer	0.000241	0.0015	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00024	0.00149	CcSEcCtD
Cefazolin—Loss of consciousness—Capecitabine—stomach cancer	0.000239	0.00148	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—stomach cancer	0.000239	0.00148	CcSEcCtD
Cefazolin—Renal failure—Epirubicin—stomach cancer	0.000238	0.00147	CcSEcCtD
Cefazolin—Asthenia—Irinotecan—stomach cancer	0.000238	0.00147	CcSEcCtD
Cefazolin—Stomatitis—Epirubicin—stomach cancer	0.000236	0.00146	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—stomach cancer	0.000235	0.00146	CcSEcCtD
Cefazolin—Hypersensitivity—Fluorouracil—stomach cancer	0.000234	0.00145	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—stomach cancer	0.000233	0.00145	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—stomach cancer	0.000232	0.00144	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—stomach cancer	0.000232	0.00144	CcSEcCtD
Cefazolin—Confusional state—Docetaxel—stomach cancer	0.000231	0.00143	CcSEcCtD
Cefazolin—Anaphylactic shock—Docetaxel—stomach cancer	0.000229	0.00142	CcSEcCtD
Cefazolin—Diarrhoea—Irinotecan—stomach cancer	0.000227	0.0014	CcSEcCtD
Cefazolin—Agranulocytosis—Epirubicin—stomach cancer	0.000226	0.0014	CcSEcCtD
Cefazolin—Shock—Docetaxel—stomach cancer	0.000225	0.0014	CcSEcCtD
Cefazolin—Pruritus—Fluorouracil—stomach cancer	0.000224	0.00139	CcSEcCtD
Cefazolin—Thrombocytopenia—Docetaxel—stomach cancer	0.000224	0.00139	CcSEcCtD
Cefazolin—Confusional state—Capecitabine—stomach cancer	0.000223	0.00138	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000222	0.00138	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—stomach cancer	0.00022	0.00136	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—stomach cancer	0.00022	0.00136	CcSEcCtD
Cefazolin—Dizziness—Irinotecan—stomach cancer	0.000219	0.00136	CcSEcCtD
Cefazolin—Haemoglobin—Epirubicin—stomach cancer	0.000218	0.00135	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—stomach cancer	0.000218	0.00135	CcSEcCtD
Cefazolin—Anorexia—Docetaxel—stomach cancer	0.000218	0.00135	CcSEcCtD
Cefazolin—Shock—Capecitabine—stomach cancer	0.000218	0.00135	CcSEcCtD
Cefazolin—Haemorrhage—Epirubicin—stomach cancer	0.000217	0.00135	CcSEcCtD
Cefazolin—Hepatitis—Epirubicin—stomach cancer	0.000217	0.00135	CcSEcCtD
Cefazolin—Diarrhoea—Fluorouracil—stomach cancer	0.000217	0.00134	CcSEcCtD
Cefazolin—Thrombocytopenia—Capecitabine—stomach cancer	0.000217	0.00134	CcSEcCtD
Cefazolin—Hypotension—Docetaxel—stomach cancer	0.000214	0.00133	CcSEcCtD
Cefazolin—Anorexia—Capecitabine—stomach cancer	0.000211	0.00131	CcSEcCtD
Cefazolin—Vomiting—Irinotecan—stomach cancer	0.000211	0.0013	CcSEcCtD
Cefazolin—Dizziness—Fluorouracil—stomach cancer	0.00021	0.0013	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—stomach cancer	0.000209	0.0013	CcSEcCtD
Cefazolin—Rash—Irinotecan—stomach cancer	0.000209	0.00129	CcSEcCtD
Cefazolin—Dermatitis—Irinotecan—stomach cancer	0.000209	0.00129	CcSEcCtD
Cefazolin—Headache—Irinotecan—stomach cancer	0.000207	0.00129	CcSEcCtD
Cefazolin—Hypotension—Capecitabine—stomach cancer	0.000207	0.00128	CcSEcCtD
Cefazolin—Erythema multiforme—Epirubicin—stomach cancer	0.000206	0.00127	CcSEcCtD
Cefazolin—Somnolence—Docetaxel—stomach cancer	0.000204	0.00126	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—stomach cancer	0.000202	0.00125	CcSEcCtD
Cefazolin—Vomiting—Fluorouracil—stomach cancer	0.000202	0.00125	CcSEcCtD
Cefazolin—Dyspepsia—Docetaxel—stomach cancer	0.000202	0.00125	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—stomach cancer	0.000201	0.00125	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—stomach cancer	0.000201	0.00125	CcSEcCtD
Cefazolin—Rash—Fluorouracil—stomach cancer	0.0002	0.00124	CcSEcCtD
Cefazolin—Dermatitis—Fluorouracil—stomach cancer	0.0002	0.00124	CcSEcCtD
Cefazolin—Decreased appetite—Docetaxel—stomach cancer	0.000199	0.00123	CcSEcCtD
Cefazolin—Headache—Fluorouracil—stomach cancer	0.000199	0.00123	CcSEcCtD
Cefazolin—Fatigue—Docetaxel—stomach cancer	0.000197	0.00122	CcSEcCtD
Cefazolin—Nausea—Irinotecan—stomach cancer	0.000197	0.00122	CcSEcCtD
Cefazolin—Pain—Docetaxel—stomach cancer	0.000196	0.00121	CcSEcCtD
Cefazolin—Cefoperazone—ALB—stomach cancer	0.000195	0.0956	CrCbGaD
Cefazolin—Dyspepsia—Capecitabine—stomach cancer	0.000195	0.00121	CcSEcCtD
Cefazolin—Decreased appetite—Capecitabine—stomach cancer	0.000193	0.00119	CcSEcCtD
Cefazolin—Fatigue—Capecitabine—stomach cancer	0.000191	0.00118	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—stomach cancer	0.00019	0.00118	CcSEcCtD
Cefazolin—Pain—Capecitabine—stomach cancer	0.00019	0.00117	CcSEcCtD
Cefazolin—Feeling abnormal—Docetaxel—stomach cancer	0.000189	0.00117	CcSEcCtD
Cefazolin—Nausea—Fluorouracil—stomach cancer	0.000188	0.00117	CcSEcCtD
Cefazolin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000187	0.00116	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—stomach cancer	0.000187	0.00116	CcSEcCtD
Cefazolin—Flatulence—Epirubicin—stomach cancer	0.000186	0.00116	CcSEcCtD
Cefazolin—Feeling abnormal—Capecitabine—stomach cancer	0.000183	0.00113	CcSEcCtD
Cefazolin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000181	0.00112	CcSEcCtD
Cefazolin—Body temperature increased—Docetaxel—stomach cancer	0.000181	0.00112	CcSEcCtD
Cefazolin—Abdominal pain—Docetaxel—stomach cancer	0.000181	0.00112	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—stomach cancer	0.000181	0.00112	CcSEcCtD
Cefazolin—Urticaria—Capecitabine—stomach cancer	0.000176	0.00109	CcSEcCtD
Cefazolin—Body temperature increased—Capecitabine—stomach cancer	0.000175	0.00109	CcSEcCtD
Cefazolin—Abdominal pain—Capecitabine—stomach cancer	0.000175	0.00109	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—stomach cancer	0.000175	0.00109	CcSEcCtD
Cefazolin—Anaemia—Epirubicin—stomach cancer	0.000175	0.00108	CcSEcCtD
Cefazolin—Agitation—Epirubicin—stomach cancer	0.000174	0.00108	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—stomach cancer	0.000173	0.00107	CcSEcCtD
Cefazolin—Syncope—Epirubicin—stomach cancer	0.00017	0.00105	CcSEcCtD
Cefazolin—Leukopenia—Epirubicin—stomach cancer	0.000169	0.00105	CcSEcCtD
Cefazolin—Hypersensitivity—Docetaxel—stomach cancer	0.000169	0.00104	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—stomach cancer	0.000166	0.00103	CcSEcCtD
Cefazolin—Loss of consciousness—Epirubicin—stomach cancer	0.000166	0.00103	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—stomach cancer	0.000165	0.00102	CcSEcCtD
Cefazolin—Asthenia—Docetaxel—stomach cancer	0.000164	0.00102	CcSEcCtD
Cefazolin—Convulsion—Epirubicin—stomach cancer	0.000164	0.00102	CcSEcCtD
Cefazolin—Hypersensitivity—Capecitabine—stomach cancer	0.000163	0.00101	CcSEcCtD
Cefazolin—Pruritus—Docetaxel—stomach cancer	0.000162	0.001	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—stomach cancer	0.000162	0.001	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—stomach cancer	0.000162	0.001	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—stomach cancer	0.000161	0.000997	CcSEcCtD
Cefazolin—Asthenia—Capecitabine—stomach cancer	0.000159	0.000985	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—stomach cancer	0.000157	0.000974	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—stomach cancer	0.000157	0.000973	CcSEcCtD
Cefazolin—Pruritus—Capecitabine—stomach cancer	0.000157	0.000972	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—stomach cancer	0.000157	0.000971	CcSEcCtD
Cefazolin—Diarrhoea—Docetaxel—stomach cancer	0.000157	0.00097	CcSEcCtD
Cefazolin—Confusional state—Epirubicin—stomach cancer	0.000156	0.000965	CcSEcCtD
Cefazolin—Anaphylactic shock—Epirubicin—stomach cancer	0.000154	0.000957	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—stomach cancer	0.000154	0.000955	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—stomach cancer	0.000154	0.000953	CcSEcCtD
Cefazolin—Ceftriaxone—ALB—stomach cancer	0.000152	0.0745	CrCbGaD
Cefazolin—Shock—Epirubicin—stomach cancer	0.000152	0.000941	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—stomach cancer	0.000152	0.00094	CcSEcCtD
Cefazolin—Diarrhoea—Capecitabine—stomach cancer	0.000152	0.00094	CcSEcCtD
Cefazolin—Dizziness—Docetaxel—stomach cancer	0.000151	0.000938	CcSEcCtD
Cefazolin—Thrombocytopenia—Epirubicin—stomach cancer	0.000151	0.000937	CcSEcCtD
Cefazolin—Anorexia—Epirubicin—stomach cancer	0.000147	0.000912	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—stomach cancer	0.000147	0.000909	CcSEcCtD
Cefazolin—Dizziness—Capecitabine—stomach cancer	0.000147	0.000908	CcSEcCtD
Cefazolin—Vomiting—Docetaxel—stomach cancer	0.000146	0.000902	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—stomach cancer	0.000145	0.0009	CcSEcCtD
Cefazolin—Rash—Docetaxel—stomach cancer	0.000144	0.000894	CcSEcCtD
Cefazolin—Hypotension—Epirubicin—stomach cancer	0.000144	0.000894	CcSEcCtD
Cefazolin—Dermatitis—Docetaxel—stomach cancer	0.000144	0.000893	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—stomach cancer	0.000144	0.000893	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—stomach cancer	0.000143	0.000889	CcSEcCtD
Cefazolin—Headache—Docetaxel—stomach cancer	0.000143	0.000889	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000143	0.000885	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—stomach cancer	0.000142	0.000881	CcSEcCtD
Cefazolin—Pain—Methotrexate—stomach cancer	0.000141	0.000874	CcSEcCtD
Cefazolin—Vomiting—Capecitabine—stomach cancer	0.000141	0.000873	CcSEcCtD
Cefazolin—Shock—Doxorubicin—stomach cancer	0.000141	0.000871	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—stomach cancer	0.00014	0.000867	CcSEcCtD
Cefazolin—Rash—Capecitabine—stomach cancer	0.00014	0.000866	CcSEcCtD
Cefazolin—Dermatitis—Capecitabine—stomach cancer	0.00014	0.000865	CcSEcCtD
Cefazolin—Headache—Capecitabine—stomach cancer	0.000139	0.00086	CcSEcCtD
Cefazolin—Somnolence—Epirubicin—stomach cancer	0.000137	0.00085	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—stomach cancer	0.000136	0.000844	CcSEcCtD
Cefazolin—Nausea—Docetaxel—stomach cancer	0.000136	0.000842	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—stomach cancer	0.000136	0.000842	CcSEcCtD
Cefazolin—Dyspepsia—Epirubicin—stomach cancer	0.000136	0.000842	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000135	0.000836	CcSEcCtD
Cefazolin—Decreased appetite—Epirubicin—stomach cancer	0.000134	0.000832	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—stomach cancer	0.000134	0.000827	CcSEcCtD
Cefazolin—Cefalotin—ALB—stomach cancer	0.000133	0.0652	CrCbGaD
Cefazolin—Fatigue—Epirubicin—stomach cancer	0.000133	0.000825	CcSEcCtD
Cefazolin—Pain—Epirubicin—stomach cancer	0.000132	0.000818	CcSEcCtD
Cefazolin—Nausea—Capecitabine—stomach cancer	0.000132	0.000816	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—stomach cancer	0.000131	0.000812	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—stomach cancer	0.00013	0.000808	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—stomach cancer	0.00013	0.000808	CcSEcCtD
Cefazolin—Feeling abnormal—Epirubicin—stomach cancer	0.000127	0.000788	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—stomach cancer	0.000127	0.000787	CcSEcCtD
Cefazolin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000126	0.000782	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—stomach cancer	0.000126	0.000779	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—stomach cancer	0.000124	0.000769	CcSEcCtD
Cefazolin—Fatigue—Doxorubicin—stomach cancer	0.000123	0.000763	CcSEcCtD
Cefazolin—Urticaria—Epirubicin—stomach cancer	0.000123	0.00076	CcSEcCtD
Cefazolin—Pain—Doxorubicin—stomach cancer	0.000122	0.000757	CcSEcCtD
Cefazolin—Abdominal pain—Epirubicin—stomach cancer	0.000122	0.000756	CcSEcCtD
Cefazolin—Body temperature increased—Epirubicin—stomach cancer	0.000122	0.000756	CcSEcCtD
Cefazolin—Hypersensitivity—Methotrexate—stomach cancer	0.000122	0.000753	CcSEcCtD
Cefazolin—Cephalexin—ALB—stomach cancer	0.000121	0.0593	CrCbGaD
Cefazolin—Asthenia—Methotrexate—stomach cancer	0.000118	0.000733	CcSEcCtD
Cefazolin—Feeling abnormal—Doxorubicin—stomach cancer	0.000118	0.000729	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000117	0.000724	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—stomach cancer	0.000117	0.000723	CcSEcCtD
Cefazolin—Hypersensitivity—Epirubicin—stomach cancer	0.000114	0.000705	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—stomach cancer	0.000114	0.000703	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—stomach cancer	0.000113	0.0007	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—stomach cancer	0.000113	0.0007	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—stomach cancer	0.000113	0.000699	CcSEcCtD
Cefazolin—Asthenia—Epirubicin—stomach cancer	0.000111	0.000686	CcSEcCtD
Cefazolin—Pruritus—Epirubicin—stomach cancer	0.000109	0.000677	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—stomach cancer	0.000109	0.000676	CcSEcCtD
Cefazolin—Diarrhoea—Epirubicin—stomach cancer	0.000106	0.000655	CcSEcCtD
Cefazolin—Hypersensitivity—Doxorubicin—stomach cancer	0.000105	0.000652	CcSEcCtD
Cefazolin—Vomiting—Methotrexate—stomach cancer	0.000105	0.00065	CcSEcCtD
Cefazolin—Rash—Methotrexate—stomach cancer	0.000104	0.000645	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—stomach cancer	0.000104	0.000644	CcSEcCtD
Cefazolin—Headache—Methotrexate—stomach cancer	0.000103	0.00064	CcSEcCtD
Cefazolin—Asthenia—Doxorubicin—stomach cancer	0.000103	0.000635	CcSEcCtD
Cefazolin—Dizziness—Epirubicin—stomach cancer	0.000102	0.000633	CcSEcCtD
Cefazolin—Pruritus—Doxorubicin—stomach cancer	0.000101	0.000626	CcSEcCtD
Cefazolin—Vomiting—Epirubicin—stomach cancer	9.82e-05	0.000608	CcSEcCtD
Cefazolin—Nausea—Methotrexate—stomach cancer	9.8e-05	0.000607	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—stomach cancer	9.78e-05	0.000606	CcSEcCtD
Cefazolin—Rash—Epirubicin—stomach cancer	9.74e-05	0.000603	CcSEcCtD
Cefazolin—Dermatitis—Epirubicin—stomach cancer	9.73e-05	0.000603	CcSEcCtD
Cefazolin—Headache—Epirubicin—stomach cancer	9.67e-05	0.000599	CcSEcCtD
Cefazolin—Dizziness—Doxorubicin—stomach cancer	9.45e-05	0.000585	CcSEcCtD
Cefazolin—Nausea—Epirubicin—stomach cancer	9.17e-05	0.000568	CcSEcCtD
Cefazolin—Vomiting—Doxorubicin—stomach cancer	9.08e-05	0.000563	CcSEcCtD
Cefazolin—Rash—Doxorubicin—stomach cancer	9.01e-05	0.000558	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—stomach cancer	9e-05	0.000558	CcSEcCtD
Cefazolin—Headache—Doxorubicin—stomach cancer	8.95e-05	0.000555	CcSEcCtD
Cefazolin—Nausea—Doxorubicin—stomach cancer	8.49e-05	0.000526	CcSEcCtD
Cefazolin—TPMT—Metabolism—CKB—stomach cancer	7.01e-05	0.00392	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NDUFA2—stomach cancer	7.01e-05	0.00392	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SPARC—stomach cancer	6.73e-05	0.00376	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—TP53—stomach cancer	6.6e-05	0.00369	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—F2R—stomach cancer	6.6e-05	0.00369	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SPARC—stomach cancer	6.6e-05	0.00369	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PLIN2—stomach cancer	6.59e-05	0.00369	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTP1—stomach cancer	6.52e-05	0.00364	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—SMAD4—stomach cancer	6.45e-05	0.00361	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—HMOX1—stomach cancer	6.43e-05	0.00359	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CA2—stomach cancer	6.41e-05	0.00359	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—stomach cancer	6.41e-05	0.00358	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINB2—stomach cancer	6.37e-05	0.00356	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SOD2—stomach cancer	6.31e-05	0.00353	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—SERPINE1—stomach cancer	6.26e-05	0.0035	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NT5E—stomach cancer	6.25e-05	0.00349	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PGAM1—stomach cancer	6.25e-05	0.00349	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC1A2—stomach cancer	6.25e-05	0.00349	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—ALB—stomach cancer	6.25e-05	0.00349	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—FYN—stomach cancer	6.13e-05	0.00343	CbGpPWpGaD
Cefazolin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—stomach cancer	6.09e-05	0.0034	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTM1—stomach cancer	5.99e-05	0.00335	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PLCE1—stomach cancer	5.96e-05	0.00333	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALDH7A1—stomach cancer	5.96e-05	0.00333	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—stomach cancer	5.96e-05	0.00333	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—stomach cancer	5.95e-05	0.00333	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—stomach cancer	5.75e-05	0.00322	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—FGFR2—stomach cancer	5.75e-05	0.00322	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—UMPS—stomach cancer	5.72e-05	0.0032	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—MTHFR—stomach cancer	5.56e-05	0.00311	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ITGA5—stomach cancer	5.46e-05	0.00305	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PDHA1—stomach cancer	5.31e-05	0.00297	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ECHS1—stomach cancer	5.31e-05	0.00297	CbGpPWpGaD
Cefazolin—ALB—Lipid and lipoprotein metabolism—CAV1—stomach cancer	5.21e-05	0.00291	CbGpPWpGaD
Cefazolin—ALB—Lipid and lipoprotein metabolism—APOA1—stomach cancer	5.2e-05	0.0029	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SOD2—stomach cancer	5.14e-05	0.00287	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—APOA1—stomach cancer	5.11e-05	0.00286	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TYMP—stomach cancer	5e-05	0.00279	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—FADS1—stomach cancer	5e-05	0.00279	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC1A2—stomach cancer	4.76e-05	0.00266	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CLCN3—stomach cancer	4.75e-05	0.00266	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SREBF2—stomach cancer	4.68e-05	0.00262	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—RORA—stomach cancer	4.62e-05	0.00258	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC1A2—stomach cancer	4.57e-05	0.00255	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—MTHFR—stomach cancer	4.52e-05	0.00253	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALDOB—stomach cancer	4.33e-05	0.00242	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—VEGFA—stomach cancer	4.3e-05	0.00241	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FGG—stomach cancer	4.3e-05	0.00241	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—THBD—stomach cancer	4.22e-05	0.00236	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—FYN—stomach cancer	4.2e-05	0.00235	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—APOA1—stomach cancer	4.16e-05	0.00233	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—stomach cancer	4.1e-05	0.00229	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SOD2—stomach cancer	4.08e-05	0.00228	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	4.07e-05	0.00227	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SERPINE1—stomach cancer	4.06e-05	0.00227	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALOX5—stomach cancer	4.03e-05	0.00225	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC1A2—stomach cancer	3.98e-05	0.00222	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—DPYD—stomach cancer	3.96e-05	0.00222	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PPIA—stomach cancer	3.9e-05	0.00218	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FGG—stomach cancer	3.78e-05	0.00211	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINA1—stomach cancer	3.76e-05	0.0021	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—MTHFR—stomach cancer	3.59e-05	0.00201	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—APOA1—stomach cancer	3.57e-05	0.00199	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTT1—stomach cancer	3.5e-05	0.00196	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—APOA1—stomach cancer	3.5e-05	0.00195	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2A6—stomach cancer	3.46e-05	0.00194	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PPIA—stomach cancer	3.43e-05	0.00192	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SPARC—stomach cancer	3.4e-05	0.0019	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—F2R—stomach cancer	3.4e-05	0.0019	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—stomach cancer	3.4e-05	0.0019	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKR1C3—stomach cancer	3.37e-05	0.00188	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	3.34e-05	0.00186	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IRF1—stomach cancer	3.33e-05	0.00186	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—ALB—stomach cancer	3.33e-05	0.00186	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—APOA1—stomach cancer	3.31e-05	0.00185	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SERPINE1—stomach cancer	3.3e-05	0.00185	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINA1—stomach cancer	3.3e-05	0.00185	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL1B—stomach cancer	3.3e-05	0.00184	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ENO1—stomach cancer	3.28e-05	0.00184	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—stomach cancer	3.24e-05	0.00181	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	3.22e-05	0.0018	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—F2R—stomach cancer	2.99e-05	0.00167	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SPARC—stomach cancer	2.99e-05	0.00167	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CD44—stomach cancer	2.91e-05	0.00163	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CD44—stomach cancer	2.89e-05	0.00162	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINB2—stomach cancer	2.88e-05	0.00161	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SERPINE1—stomach cancer	2.83e-05	0.00158	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.82e-05	0.00157	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	2.78e-05	0.00155	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—ALB—stomach cancer	2.77e-05	0.00155	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—stomach cancer	2.7e-05	0.00151	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	2.7e-05	0.00151	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL1B—stomach cancer	2.68e-05	0.0015	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—RHOA—stomach cancer	2.68e-05	0.0015	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SERPINE1—stomach cancer	2.62e-05	0.00147	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—stomach cancer	2.56e-05	0.00143	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—ALB—stomach cancer	2.54e-05	0.00142	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPP2R1A—stomach cancer	2.48e-05	0.00138	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGA5—stomach cancer	2.47e-05	0.00138	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PPP2R1A—stomach cancer	2.46e-05	0.00137	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTP1—stomach cancer	2.43e-05	0.00136	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—HMOX1—stomach cancer	2.4e-05	0.00134	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—TNF—stomach cancer	2.39e-05	0.00134	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PTGS2—stomach cancer	2.29e-05	0.00128	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TYMS—stomach cancer	2.26e-05	0.00126	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTM1—stomach cancer	2.23e-05	0.00125	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACAD8—stomach cancer	2.22e-05	0.00124	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	2.17e-05	0.00122	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FYN—stomach cancer	2.17e-05	0.00121	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.15e-05	0.0012	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—APOA1—stomach cancer	2.13e-05	0.00119	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL1B—stomach cancer	2.13e-05	0.00119	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—ALB—stomach cancer	2.12e-05	0.00118	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ERCC2—stomach cancer	2.1e-05	0.00117	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.07e-05	0.00116	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.06e-05	0.00115	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	2.04e-05	0.00114	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GMPR2—stomach cancer	1.98e-05	0.00111	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—stomach cancer	1.97e-05	0.0011	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—stomach cancer	1.95e-05	0.00109	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—stomach cancer	1.95e-05	0.00109	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FGG—stomach cancer	1.95e-05	0.00109	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—stomach cancer	1.93e-05	0.00108	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	1.91e-05	0.00107	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.91e-05	0.00107	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—THBD—stomach cancer	1.91e-05	0.00107	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FYN—stomach cancer	1.9e-05	0.00106	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—RORA—stomach cancer	1.89e-05	0.00106	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—stomach cancer	1.86e-05	0.00104	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PLAU—stomach cancer	1.85e-05	0.00103	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CAV1—stomach cancer	1.82e-05	0.00102	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—APOA1—stomach cancer	1.82e-05	0.00101	CbGpPWpGaD
Cefazolin—ALB—Metabolism—IDH3B—stomach cancer	1.81e-05	0.00101	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SUCLG1—stomach cancer	1.81e-05	0.00101	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CAV1—stomach cancer	1.81e-05	0.00101	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.81e-05	0.00101	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—APOA1—stomach cancer	1.8e-05	0.00101	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.79e-05	0.001	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PPIA—stomach cancer	1.77e-05	0.000988	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PRKCB—stomach cancer	1.72e-05	0.000961	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.72e-05	0.000961	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—stomach cancer	1.72e-05	0.00096	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINA1—stomach cancer	1.7e-05	0.000951	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—stomach cancer	1.69e-05	0.000945	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NDUFV1—stomach cancer	1.69e-05	0.000942	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NDUFS1—stomach cancer	1.69e-05	0.000942	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	1.65e-05	0.000921	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—APOA1—stomach cancer	1.63e-05	0.00091	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARG—stomach cancer	1.6e-05	0.000894	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—APOA1—stomach cancer	1.58e-05	0.000885	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—stomach cancer	1.57e-05	0.000878	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—APOA1—stomach cancer	1.56e-05	0.000872	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—stomach cancer	1.55e-05	0.000865	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SPARC—stomach cancer	1.54e-05	0.00086	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—F2R—stomach cancer	1.54e-05	0.00086	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	1.51e-05	0.000844	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IRF1—stomach cancer	1.51e-05	0.000842	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BLVRB—stomach cancer	1.5e-05	0.00084	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PGLS—stomach cancer	1.5e-05	0.00084	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.49e-05	0.000834	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—stomach cancer	1.44e-05	0.000804	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPAP2A—stomach cancer	1.43e-05	0.000801	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—stomach cancer	1.43e-05	0.0008	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—stomach cancer	1.43e-05	0.000798	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RHOA—stomach cancer	1.38e-05	0.000772	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.38e-05	0.000771	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NOS3—stomach cancer	1.38e-05	0.000769	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS3—stomach cancer	1.37e-05	0.000764	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—APOA1—stomach cancer	1.36e-05	0.000759	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD44—stomach cancer	1.31e-05	0.000731	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—stomach cancer	1.29e-05	0.000721	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FBP1—stomach cancer	1.28e-05	0.000714	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CA1—stomach cancer	1.28e-05	0.000714	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CKB—stomach cancer	1.28e-05	0.000714	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NDUFA2—stomach cancer	1.28e-05	0.000714	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—stomach cancer	1.26e-05	0.000703	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	1.26e-05	0.000702	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—stomach cancer	1.25e-05	0.000698	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—stomach cancer	1.24e-05	0.000691	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RHOA—stomach cancer	1.21e-05	0.000677	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLIN2—stomach cancer	1.2e-05	0.000672	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CA2—stomach cancer	1.17e-05	0.000653	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NT5E—stomach cancer	1.14e-05	0.000637	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PGAM1—stomach cancer	1.14e-05	0.000637	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PPP2R1A—stomach cancer	1.11e-05	0.000622	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLCE1—stomach cancer	1.09e-05	0.000607	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDH7A1—stomach cancer	1.09e-05	0.000607	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	1.08e-05	0.000602	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UMPS—stomach cancer	1.04e-05	0.000582	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—stomach cancer	9.84e-06	0.00055	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FYN—stomach cancer	9.81e-06	0.000548	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PDHA1—stomach cancer	9.68e-06	0.000541	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ECHS1—stomach cancer	9.68e-06	0.000541	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.32e-06	0.000521	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK3—stomach cancer	9.31e-06	0.00052	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FADS1—stomach cancer	9.1e-06	0.000509	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TYMP—stomach cancer	9.1e-06	0.000509	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK1—stomach cancer	8.86e-06	0.000495	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	8.64e-06	0.000483	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SREBF2—stomach cancer	8.52e-06	0.000477	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RORA—stomach cancer	8.42e-06	0.000471	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAU—stomach cancer	8.37e-06	0.000468	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—stomach cancer	8.37e-06	0.000468	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CAV1—stomach cancer	8.17e-06	0.000457	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	8.17e-06	0.000457	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—APOA1—stomach cancer	8.16e-06	0.000456	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDOB—stomach cancer	7.89e-06	0.000441	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCB—stomach cancer	7.78e-06	0.000435	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	7.78e-06	0.000435	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—stomach cancer	7.74e-06	0.000433	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—stomach cancer	7.69e-06	0.00043	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.44e-06	0.000416	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—stomach cancer	7.44e-06	0.000416	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.43e-06	0.000415	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALOX5—stomach cancer	7.34e-06	0.00041	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DPYD—stomach cancer	7.22e-06	0.000404	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HRAS—stomach cancer	7.11e-06	0.000398	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	7.06e-06	0.000395	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	6.75e-06	0.000377	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.54e-06	0.000366	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—stomach cancer	6.47e-06	0.000362	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—stomach cancer	6.38e-06	0.000357	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2A6—stomach cancer	6.31e-06	0.000353	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RHOA—stomach cancer	6.25e-06	0.000349	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS3—stomach cancer	6.18e-06	0.000346	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKR1C3—stomach cancer	6.14e-06	0.000343	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENO1—stomach cancer	5.98e-06	0.000334	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CD44—stomach cancer	5.3e-06	0.000297	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.15e-06	0.000288	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPP2R1A—stomach cancer	4.51e-06	0.000252	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—stomach cancer	4.45e-06	0.000249	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—stomach cancer	4.42e-06	0.000247	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—stomach cancer	4.36e-06	0.000244	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK3—stomach cancer	4.21e-06	0.000236	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TYMS—stomach cancer	4.11e-06	0.00023	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—stomach cancer	4.07e-06	0.000227	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK1—stomach cancer	4.01e-06	0.000224	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ERCC2—stomach cancer	3.82e-06	0.000214	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—stomach cancer	3.79e-06	0.000212	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—stomach cancer	3.59e-06	0.000201	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—stomach cancer	3.48e-06	0.000194	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—stomach cancer	3.36e-06	0.000188	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAV1—stomach cancer	3.31e-06	0.000185	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOA1—stomach cancer	3.31e-06	0.000185	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HRAS—stomach cancer	3.22e-06	0.00018	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.17e-06	0.000177	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARG—stomach cancer	2.91e-06	0.000163	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NOS3—stomach cancer	2.51e-06	0.00014	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—stomach cancer	2.29e-06	0.000128	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—stomach cancer	1.41e-06	7.88e-05	CbGpPWpGaD
